NCT01578252View on ClinicalTrials.gov

Bioequivalence Study of Ondansetron Tablets USP 8 mg Under Fasting Condition

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

September 30, 2011

Study Completion Date

September 30, 2011

Conditions
Fasting State
Interventions
DRUG

Ondansetron Tablets USP 8 mg

8 mg tablet once a day

DRUG

Ondansetron Hydrochloride

8 mg tablet once a day

Trial Locations (1)

Unknown

Accutest Research Lab (I) Pvt. Ltd., Ahmedabad

Sponsors
All Listed Sponsors
lead

IPCA Laboratories Ltd.

INDUSTRY